Report : North America DVT Preventive Pump Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Type (Lower Extremity and Upper Extremity) and End User (Hospitals and Clinics, Surgical Centers, and Others)
At 4.7% CAGR, the North America DVT Preventive Pump Market is speculated to be worth US$ 209.64 million by 2028, says Business Market Insights
According to Business Market Insights’ research, the North America DVT preventive pump market was valued at US$ 159.01 million in 2022 and is expected to reach US$ 209.64 million by 2028, registering a CAGR of 4.7% from 2022 to 2028. Rising cases of cardiac disorders and stroke and significant surge in geriatric population and rising prevalence of deep vein thrombosis are the critical factors attributed to the North America DVT preventive pump market expansion.
Deep vein thrombosis (DVT) is a condition that occurs when a blood clot (thrombus) is formed in one or more veins, especially in the lower extremities. It can cause pain and swelling, and in some cases, it led to pulmonary embolism, a life-threatening condition. Cardiovascular and stroke patients are more prone to DVT as the condition affects the overall blood flow of the body. According to the Centers for Disease Control and Prevention (CDC), approximately 900,000 people are expected to be affected by DVT or pulmonary embolism annually in the US, and ~60,000-100,000 deaths are registered in the country every year. Moreover, the geriatric population is susceptible to DVT as they have restricted movements along with other chronic conditions, such as diabetes and orthopedic disorders, which contribute to the prevalence of DVT. According to the National Library of medicine, the risk of venous thromboembolism (VTE) is higher in the population aged 65 years or more, and the risk in patients above 70 years old are four to six times higher than in younger patients additionally coexisting comorbidities are exhibiting high mortality rate among geriatric population. As a result, the life expectancy of people has increased in these countries, leading to a growth in their geriatric population base. Further, the US Census Bureau report states that the number of people in the US aged 65 and above is anticipated to grow from 46 million in 2016 to over ~98 million by 2060, registering an increase from ~15% to ~24% during this period. As per the same report, underdeveloped and developing countries are expected to account for ~80% of this population growth. This is expected to drive the North America DVT preventive pump market during the forecast period.
On the contrary, lack of skilled professionals, side effects associated with pumps, and availability of alternatives hurdles the growth of North America DVT preventive pump market.
Based on type, the North America DVT preventive pump market is bifurcated into lower extremity and upper extremity. The lower extremity segment held 79.3% market share in 2022, amassing US$ 126.04 million. It is projected to garner US$ 168.95 million by 2028 to expand at 5.0% CAGR during 2022–2028.
Based on end user, the North America DVT preventive pump market is categorized into hospitals and clinics, surgical centres, and others. The hospitals and clinics segment held 45.6% of the North America DVT preventive pump market share in 2022, amassing US$ 72.51 million. It is projected to garner US$ 98.75 million by 2028 to expand at 5.3% CAGR during 2022–2028.
Based on country, the North America DVT preventive pump market has been categorized into the US, Canada, and Mexico. Our regional analysis states that the US captured 65.1% of the North America DVT preventive pump market share in 2022. It was assessed at US$ 103.60 million in 2022 and is likely to hit US$ 139.30 million by 2028, exhibiting a CAGR of 5.1% during the forecast period.
Key players dominating the North America DVT preventive pump market are Devo Medical Products Inc.; Breg Inc.; Bio Compression Systems Inc.; Cardinal Health Inc.; Arjo AB; Mego Afek Ltd.; DJO LLC; Currie Medical Specialities Inc.; Zimmer Biomet Holdings Inc.; and ThermoTek Inc. among others.
Contact Person: Sameer Joshi
Email Id: email@example.com